Neogen Chemicals: Promoter Haridas Kanani Gifts 57.78 Lakh Shares to Family Trusts
Promoter Haridas Thakarshi Kanani gifted 57,78,500 equity shares of Neogen Chemicals to two family trusts on December 31, 2025. Haridas Kanani Family Trust received 52,76,500 shares, and H T Kanani Family Trust received 5,02,000 shares via off-market transactions. These acquisitions are classified as promoter group shareholdings.
The transaction is an off-market gift of shares between a promoter and family trusts. While it involves a significant number of shares, it represents a restructuring of ownership within the promoter group rather than a change in beneficial ownership or a sale to external parties. Therefore, the immediate market impact is expected to be minimal.
The transaction involves a gift of shares between related entities (Promoter to Family Trusts), which is a common practice and does not inherently indicate a positive or negative change in the company's fundamentals or outlook. It's a disclosure of a change in shareholding structure within the promoter group.
Neogen Chemicals Limited announced that Haridas Thakarshi Kanani, Promoter and Chairman Emeritus, has gifted 57,78,500 equity shares, representing 21.90% of the company's paid-up capital, to Haridas Kanani Family Trust and H T Kanani Family Trust. This transaction was conducted via an off-market gift on December 31, 2025.
Following this gift, Haridas Kanani's direct shareholding has reduced, while the family trusts have acquired these shares. The Haridas Kanani Family Trust acquired 52,76,500 equity shares, and the H T Kanani Family Trust acquired 5,02,000 equity shares. These acquisitions are classified as promoter group shareholdings post-acquisition, following a SEBI Exemption Order dated December 30, 2025.
The disclosure was made pursuant to Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, with the disclosures submitted by the company on January 2, 2026, well within the prescribed time limits. The closing price of Neogen Chemicals on NSE as of December 30, 2025, was ₹1,163.20.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under substantial acquisition of shares and takeovers. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.